

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 8.28329596 |
| 2 | * digestion (GO:0007586) | 7.65147507 |
| 3 | acylglycerol catabolic process (GO:0046464) | 7.41384220 |
| 4 | neutral lipid catabolic process (GO:0046461) | 7.41384220 |
| 5 | biotin metabolic process (GO:0006768) | 7.22402318 |
| 6 | lipid storage (GO:0019915) | 7.06075281 |
| 7 | diacylglycerol metabolic process (GO:0046339) | 6.90988681 |
| 8 | cellular response to cadmium ion (GO:0071276) | 6.61289393 |
| 9 | fatty acid homeostasis (GO:0055089) | 6.34114205 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 6.30873339 |
| 11 | lipid particle organization (GO:0034389) | 5.66308758 |
| 12 | positive regulation of lipid storage (GO:0010884) | 5.61489798 |
| 13 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 5.34483632 |
| 14 | glycerolipid catabolic process (GO:0046503) | 5.26917660 |
| 15 | triglyceride metabolic process (GO:0006641) | 5.19451404 |
| 16 | CDP-diacylglycerol metabolic process (GO:0046341) | 5.13086690 |
| 17 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.10854775 |
| 18 | triglyceride biosynthetic process (GO:0019432) | 5.05595526 |
| 19 | acylglycerol metabolic process (GO:0006639) | 4.92349844 |
| 20 | neutral lipid biosynthetic process (GO:0046460) | 4.89912304 |
| 21 | acylglycerol biosynthetic process (GO:0046463) | 4.89912304 |
| 22 | neutral lipid metabolic process (GO:0006638) | 4.85891250 |
| 23 | regulation of lipid storage (GO:0010883) | 4.76571295 |
| 24 | negative regulation of lipid storage (GO:0010888) | 4.69856737 |
| 25 | negative regulation of lipid catabolic process (GO:0050995) | 4.67242629 |
| 26 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.66879624 |
| 27 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.61716749 |
| 28 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.29002627 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 4.19424011 |
| 30 | protein heterotrimerization (GO:0070208) | 4.11372318 |
| 31 | oxaloacetate metabolic process (GO:0006107) | 3.93047961 |
| 32 | acyl-CoA biosynthetic process (GO:0071616) | 3.84232649 |
| 33 | thioester biosynthetic process (GO:0035384) | 3.84232649 |
| 34 | positive regulation of lipid catabolic process (GO:0050996) | 3.82726707 |
| 35 | carnitine shuttle (GO:0006853) | 3.80726248 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 3.78914519 |
| 37 | regulation of lipid catabolic process (GO:0050994) | 3.76016407 |
| 38 | response to phenylpropanoid (GO:0080184) | 3.69765055 |
| 39 | brown fat cell differentiation (GO:0050873) | 3.69134386 |
| 40 | phosphatidic acid metabolic process (GO:0046473) | 3.64623949 |
| 41 | phosphatidic acid biosynthetic process (GO:0006654) | 3.64623949 |
| 42 | white fat cell differentiation (GO:0050872) | 3.62257864 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 3.61273694 |
| 44 | response to dietary excess (GO:0002021) | 3.55751974 |
| 45 | L-serine transport (GO:0015825) | 3.55531539 |
| 46 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.54647384 |
| 47 | positive regulation of glomerulus development (GO:0090193) | 3.52504069 |
| 48 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.51891355 |
| 49 | negative regulation of protein autophosphorylation (GO:0031953) | 3.49388419 |
| 50 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.47333424 |
| 51 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.46229906 |
| 52 | regulation of triglyceride metabolic process (GO:0090207) | 3.45358115 |
| 53 | positive regulation of cholesterol efflux (GO:0010875) | 3.43536450 |
| 54 | regulation of execution phase of apoptosis (GO:1900117) | 3.39988587 |
| 55 | regulation of cholesterol storage (GO:0010885) | 3.39449837 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.38891210 |
| 57 | ovulation from ovarian follicle (GO:0001542) | 3.38369487 |
| 58 | skeletal muscle organ development (GO:0060538) | 3.36015083 |
| 59 | response to zinc ion (GO:0010043) | 3.35654520 |
| 60 | negative regulation of macrophage differentiation (GO:0045650) | 3.32198783 |
| 61 | ethanol oxidation (GO:0006069) | 3.31233609 |
| 62 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.30492163 |
| 63 | positive regulation of p38MAPK cascade (GO:1900745) | 3.30358423 |
| 64 | negative regulation of platelet activation (GO:0010544) | 3.27391964 |
| 65 | negative regulation of norepinephrine secretion (GO:0010700) | 3.23673937 |
| 66 | alanine transport (GO:0032328) | 3.23474584 |
| 67 | serine transport (GO:0032329) | 3.22368728 |
| 68 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.16766054 |
| 69 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.13385831 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.12173163 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.12173163 |
| 72 | cAMP biosynthetic process (GO:0006171) | 3.10561591 |
| 73 | ovulation cycle (GO:0042698) | 3.09542191 |
| 74 | NADH metabolic process (GO:0006734) | 3.04785052 |
| 75 | retinol metabolic process (GO:0042572) | 3.02226183 |
| 76 | cellular response to epinephrine stimulus (GO:0071872) | 2.99228043 |
| 77 | positive regulation of metanephros development (GO:0072216) | 2.99133766 |
| 78 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.98431816 |
| 79 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.97990235 |
| 80 | potassium ion export (GO:0071435) | 2.95662244 |
| 81 | valine metabolic process (GO:0006573) | 2.94049805 |
| 82 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90644090 |
| 83 | positive regulation of sterol transport (GO:0032373) | 2.89907998 |
| 84 | positive regulation of cholesterol transport (GO:0032376) | 2.89907998 |
| 85 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.87108740 |
| 86 | positive regulation of urine volume (GO:0035810) | 2.86934687 |
| 87 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.86079940 |
| 88 | acyl-CoA metabolic process (GO:0006637) | 2.85379124 |
| 89 | thioester metabolic process (GO:0035383) | 2.85379124 |
| 90 | response to hydroperoxide (GO:0033194) | 2.85290743 |
| 91 | positive regulation of glycolytic process (GO:0045821) | 2.85148554 |
| 92 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80393255 |
| 93 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.80170103 |
| 94 | regulation of p38MAPK cascade (GO:1900744) | 2.80106470 |
| 95 | carnitine transmembrane transport (GO:1902603) | 2.79598845 |
| 96 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.79062597 |
| 97 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.75202765 |
| 98 | regulation of sequestering of triglyceride (GO:0010889) | 11.2978076 |
| 99 | cellular response to zinc ion (GO:0071294) | 10.1467726 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 10.0911168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.96258835 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.81399114 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.74471493 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71755379 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.48057275 |
| 6 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 3.20498844 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.19703605 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34686693 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30898282 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27699581 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27478387 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.19053489 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15021083 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11605466 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.04219807 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.02869540 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.00885625 |
| 18 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.00885625 |
| 19 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.00885625 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98374590 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95383985 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.94605415 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66972368 |
| 24 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64416447 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51095510 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43034765 |
| 27 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40424161 |
| 28 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40424161 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36719996 |
| 30 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.35666297 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34672339 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32519162 |
| 33 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.30968014 |
| 34 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29913439 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27619137 |
| 36 | CBP_21632823_ChIP-Seq_H3396_Human | 1.26530124 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26069276 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24895566 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23996853 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23280435 |
| 41 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.21719777 |
| 42 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.20359969 |
| 43 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.20182459 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18061616 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14203744 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14160502 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13515587 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13247972 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10783425 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10140320 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07280430 |
| 52 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06305943 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04801406 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02711503 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02517416 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01315963 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99692617 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98575025 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98575025 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.97608005 |
| 61 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97583150 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97372028 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95453687 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93304434 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 0.93209158 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92118800 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90896260 |
| 68 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90542883 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89943956 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88880025 |
| 71 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88539219 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87958238 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87447913 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 0.87298101 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87069319 |
| 76 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85534405 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85369031 |
| 78 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84988347 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84541298 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84002249 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83530376 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83040324 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82672862 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82541481 |
| 85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82479475 |
| 86 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82247533 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81046113 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76496247 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76425361 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76389728 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75433373 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73482359 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73436613 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73010802 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72821885 |
| 96 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.72539733 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.71913115 |
| 98 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.71363322 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.70870784 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.70715404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.50608423 |
| 2 | MP0008004_abnormal_stomach_pH | 4.94761120 |
| 3 | MP0005666_abnormal_adipose_tissue | 4.83818756 |
| 4 | MP0002971_abnormal_brown_adipose | 4.58624276 |
| 5 | MP0004130_abnormal_muscle_cell | 3.59167257 |
| 6 | MP0005375_adipose_tissue_phenotype | 3.20797174 |
| 7 | MP0003724_increased_susceptibility_to | 3.06510628 |
| 8 | MP0005083_abnormal_biliary_tract | 2.95361752 |
| 9 | MP0005334_abnormal_fat_pad | 2.89751361 |
| 10 | MP0006138_congestive_heart_failure | 2.81602481 |
| 11 | MP0002970_abnormal_white_adipose | 2.78489891 |
| 12 | MP0005535_abnormal_body_temperature | 2.70482852 |
| 13 | MP0000343_altered_response_to | 2.48931989 |
| 14 | MP0009115_abnormal_fat_cell | 2.43773892 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.26823700 |
| 16 | MP0003303_peritoneal_inflammation | 2.25294500 |
| 17 | MP0003959_abnormal_lean_body | 2.08171219 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.04089648 |
| 19 | MP0005647_abnormal_sex_gland | 2.03985399 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.98059958 |
| 21 | MP0005448_abnormal_energy_balance | 1.96952912 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.91553401 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.89232925 |
| 24 | MP0002295_abnormal_pulmonary_circulatio | 1.87046002 |
| 25 | MP0009840_abnormal_foam_cell | 1.85302962 |
| 26 | MP0001661_extended_life_span | 1.79399026 |
| 27 | MP0003868_abnormal_feces_composition | 1.75552091 |
| 28 | MP0003828_pulmonary_edema | 1.74065316 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.64031843 |
| 30 | MP0005452_abnormal_adipose_tissue | 1.61555524 |
| 31 | MP0009278_abnormal_bone_marrow | 1.56459713 |
| 32 | MP0005365_abnormal_bile_salt | 1.52774020 |
| 33 | MP0005595_abnormal_vascular_smooth | 1.46921568 |
| 34 | MP0003011_delayed_dark_adaptation | 1.44249584 |
| 35 | MP0003879_abnormal_hair_cell | 1.42469235 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.39011360 |
| 37 | MP0002078_abnormal_glucose_homeostasis | 1.38882670 |
| 38 | MP0000751_myopathy | 1.27369938 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.26203971 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.23865182 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.22234092 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.22234092 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.21856337 |
| 44 | MP0003186_abnormal_redox_activity | 1.19958264 |
| 45 | MP0002254_reproductive_system_inflammat | 1.11312408 |
| 46 | MP0005410_abnormal_fertilization | 1.10609811 |
| 47 | MP0004510_myositis | 1.09637119 |
| 48 | MP0005164_abnormal_response_to | 1.07762901 |
| 49 | MP0004272_abnormal_basement_membrane | 1.06651027 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.06145379 |
| 51 | MP0003948_abnormal_gas_homeostasis | 1.03861570 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.02824296 |
| 53 | MP0004858_abnormal_nervous_system | 1.02253135 |
| 54 | MP0000609_abnormal_liver_physiology | 1.01458368 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01119415 |
| 56 | MP0000249_abnormal_blood_vessel | 1.01067764 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97013810 |
| 58 | MP0001544_abnormal_cardiovascular_syste | 0.94899063 |
| 59 | MP0005385_cardiovascular_system_phenoty | 0.94899063 |
| 60 | MP0003953_abnormal_hormone_level | 0.93677075 |
| 61 | MP0003950_abnormal_plasma_membrane | 0.93571940 |
| 62 | MP0001764_abnormal_homeostasis | 0.92505080 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 0.90101327 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.89119836 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.88743126 |
| 66 | MP0001664_abnormal_digestion | 0.86509620 |
| 67 | MP0004036_abnormal_muscle_relaxation | 0.85795328 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.84889661 |
| 69 | MP0003690_abnormal_glial_cell | 0.83827146 |
| 70 | MP0000230_abnormal_systemic_arterial | 0.83151953 |
| 71 | MP0001542_abnormal_bone_strength | 0.82679663 |
| 72 | MP0002132_abnormal_respiratory_system | 0.81783416 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.79423976 |
| 74 | MP0001727_abnormal_embryo_implantation | 0.78597934 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.78347282 |
| 76 | MP0003279_aneurysm | 0.76980612 |
| 77 | MP0001533_abnormal_skeleton_physiology | 0.76769737 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 0.76769532 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.74260515 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 0.74043719 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.73912394 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.73156795 |
| 83 | MP0000749_muscle_degeneration | 0.72671922 |
| 84 | MP0001944_abnormal_pancreas_morphology | 0.69489289 |
| 85 | MP0003436_decreased_susceptibility_to | 0.69130200 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.66677388 |
| 87 | MP0001501_abnormal_sleep_pattern | 0.64128628 |
| 88 | MP0004087_abnormal_muscle_fiber | 0.63074065 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.62848842 |
| 90 | MP0003075_altered_response_to | 0.62658772 |
| 91 | MP0003448_altered_tumor_morphology | 0.61685665 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.61198843 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.60498838 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 0.60246345 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.59040188 |
| 96 | MP0000604_amyloidosis | 0.57463255 |
| 97 | MP0002419_abnormal_innate_immunity | 0.57193730 |
| 98 | MP0002796_impaired_skin_barrier | 0.56017240 |
| 99 | MP0005332_abnormal_amino_acid | 0.55266815 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.51423258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertriglyceridemia (HP:0002155) | 8.09589542 |
| 2 | Difficulty running (HP:0009046) | 6.75928394 |
| 3 | Acanthosis nigricans (HP:0000956) | 6.54634706 |
| 4 | Long foot (HP:0001833) | 6.07404103 |
| 5 | Oligomenorrhea (HP:0000876) | 5.98324116 |
| 6 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.15942775 |
| 7 | Axonal loss (HP:0003447) | 5.04961814 |
| 8 | Insulin resistance (HP:0000855) | 4.53611776 |
| 9 | Complement deficiency (HP:0004431) | 4.53529324 |
| 10 | Polyphagia (HP:0002591) | 4.46951628 |
| 11 | Increased muscle lipid content (HP:0009058) | 4.38294981 |
| 12 | Growth hormone excess (HP:0000845) | 4.37374877 |
| 13 | Bone cyst (HP:0012062) | 4.24250256 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.75575687 |
| 15 | Abnormality of complement system (HP:0005339) | 3.74172533 |
| 16 | Easy fatigability (HP:0003388) | 3.71616243 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.59752435 |
| 18 | Prominent supraorbital ridges (HP:0000336) | 3.51616736 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.41671122 |
| 20 | Abnormality of alanine metabolism (HP:0010916) | 3.34228510 |
| 21 | Hyperalaninemia (HP:0003348) | 3.34228510 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.34228510 |
| 23 | Epidermoid cyst (HP:0200040) | 3.20820871 |
| 24 | Neck muscle weakness (HP:0000467) | 3.10467380 |
| 25 | Abnormality of the periventricular white matter (HP:0002518) | 3.08935222 |
| 26 | Nausea (HP:0002018) | 3.06311711 |
| 27 | Resting tremor (HP:0002322) | 3.02910412 |
| 28 | Myocardial infarction (HP:0001658) | 3.01217258 |
| 29 | Increased serum pyruvate (HP:0003542) | 2.98774685 |
| 30 | Xanthomatosis (HP:0000991) | 2.96209667 |
| 31 | Clitoromegaly (HP:0000057) | 2.93582922 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.87606699 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.83197826 |
| 34 | Glomerulonephritis (HP:0000099) | 2.82930043 |
| 35 | Pancreatitis (HP:0001733) | 2.76745923 |
| 36 | Metaphyseal dysplasia (HP:0100255) | 2.76648401 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.67360178 |
| 38 | Mutism (HP:0002300) | 2.64981394 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.58452704 |
| 40 | Gowers sign (HP:0003391) | 2.56968207 |
| 41 | Lymphangioma (HP:0100764) | 2.53955109 |
| 42 | Accelerated skeletal maturation (HP:0005616) | 2.52395500 |
| 43 | Abnormality of glycolysis (HP:0004366) | 2.52288908 |
| 44 | Large hands (HP:0001176) | 2.51800608 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.51040733 |
| 46 | Joint hemorrhage (HP:0005261) | 2.49272268 |
| 47 | Steatorrhea (HP:0002570) | 2.43651874 |
| 48 | Aortic aneurysm (HP:0004942) | 2.42195803 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39715475 |
| 50 | Turricephaly (HP:0000262) | 2.38340908 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.37919107 |
| 52 | Difficulty walking (HP:0002355) | 2.35088856 |
| 53 | Hypercortisolism (HP:0001578) | 2.27772219 |
| 54 | Skin nodule (HP:0200036) | 2.27333910 |
| 55 | Infantile muscular hypotonia (HP:0008947) | 2.26783397 |
| 56 | Ileus (HP:0002595) | 2.24601186 |
| 57 | Opisthotonus (HP:0002179) | 2.18303397 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.17772773 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.14684857 |
| 60 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13531122 |
| 61 | Exocrine pancreatic insufficiency (HP:0001738) | 2.11425811 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.05830789 |
| 63 | Lipoatrophy (HP:0100578) | 2.04245420 |
| 64 | Nuclear cataract (HP:0100018) | 2.03302688 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01229361 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 1.97283355 |
| 67 | Colitis (HP:0002583) | 1.97161465 |
| 68 | Myokymia (HP:0002411) | 1.96038130 |
| 69 | Subcapsular cataract (HP:0000523) | 1.95899077 |
| 70 | Amyloidosis (HP:0011034) | 1.90478580 |
| 71 | Abnormality of the labia (HP:0000058) | 1.89784777 |
| 72 | Impulsivity (HP:0100710) | 1.85458536 |
| 73 | Polycythemia (HP:0001901) | 1.81776458 |
| 74 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.79347518 |
| 75 | Nephritis (HP:0000123) | 1.79298858 |
| 76 | Loss of speech (HP:0002371) | 1.78778073 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78414573 |
| 78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77707360 |
| 79 | Portal hypertension (HP:0001409) | 1.77155998 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 1.76901076 |
| 81 | Polar cataract (HP:0010696) | 1.76066232 |
| 82 | Hypophosphatemic rickets (HP:0004912) | 1.76050622 |
| 83 | Hyperpituitarism (HP:0010514) | 1.75556730 |
| 84 | Malnutrition (HP:0004395) | 1.75467466 |
| 85 | Cerebral aneurysm (HP:0004944) | 1.74018205 |
| 86 | Spinal rigidity (HP:0003306) | 1.73115432 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70094710 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70094710 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70094710 |
| 90 | Esophageal varix (HP:0002040) | 1.69930271 |
| 91 | Fat malabsorption (HP:0002630) | 1.69537865 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69184921 |
| 93 | Abnormality of the hepatic vasculature (HP:0006707) | 1.68769053 |
| 94 | Ectopia lentis (HP:0001083) | 1.68547054 |
| 95 | Stridor (HP:0010307) | 1.68290307 |
| 96 | Hematochezia (HP:0002573) | 1.66089222 |
| 97 | Choanal stenosis (HP:0000452) | 1.65826936 |
| 98 | Pulmonary hypertension (HP:0002092) | 1.64581042 |
| 99 | Glomerulopathy (HP:0100820) | 1.64122105 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.64047395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.40984701 |
| 2 | PRKAA2 | 3.39619836 |
| 3 | ERN1 | 3.05303256 |
| 4 | TGFBR2 | 3.02183865 |
| 5 | MAP3K6 | 2.90326448 |
| 6 | TIE1 | 2.79393159 |
| 7 | PINK1 | 2.68036424 |
| 8 | CAMK1D | 2.51862958 |
| 9 | EPHB2 | 2.23150304 |
| 10 | RIPK1 | 2.08562412 |
| 11 | SIK1 | 1.96705432 |
| 12 | EPHA3 | 1.87119177 |
| 13 | TESK1 | 1.84377382 |
| 14 | CAMK1 | 1.81408522 |
| 15 | CAMK1G | 1.71335407 |
| 16 | MOS | 1.67433873 |
| 17 | MAPK15 | 1.66590844 |
| 18 | PDK2 | 1.55618346 |
| 19 | MAP3K13 | 1.53891266 |
| 20 | MAPK4 | 1.51287472 |
| 21 | LATS2 | 1.42162301 |
| 22 | PRKAA1 | 1.40157084 |
| 23 | ZAP70 | 1.38797455 |
| 24 | PIK3CG | 1.38699243 |
| 25 | ADRBK1 | 1.35509989 |
| 26 | PIM2 | 1.26794546 |
| 27 | BLK | 1.26664127 |
| 28 | TAOK2 | 1.25940288 |
| 29 | ABL2 | 1.23482235 |
| 30 | CAMKK2 | 1.22995215 |
| 31 | BMX | 1.22830493 |
| 32 | ARAF | 1.19697880 |
| 33 | JAK2 | 1.19119735 |
| 34 | EPHB1 | 1.18887039 |
| 35 | CLK1 | 1.18652925 |
| 36 | KDR | 1.16738061 |
| 37 | LATS1 | 1.15154928 |
| 38 | PDGFRA | 1.11958349 |
| 39 | MAPK12 | 1.04605879 |
| 40 | PDGFRB | 1.04562576 |
| 41 | DDR2 | 1.02780322 |
| 42 | MARK3 | 1.01000333 |
| 43 | MAP3K1 | 0.99118677 |
| 44 | MAP3K3 | 0.98068406 |
| 45 | PRKACG | 0.97145031 |
| 46 | CDK6 | 0.96580066 |
| 47 | JAK3 | 0.94360356 |
| 48 | TGFBR1 | 0.93985595 |
| 49 | RIPK4 | 0.90738014 |
| 50 | DMPK | 0.89933721 |
| 51 | CDK9 | 0.89697363 |
| 52 | FES | 0.89649298 |
| 53 | PDPK1 | 0.87763088 |
| 54 | INSRR | 0.86616827 |
| 55 | MTOR | 0.86561618 |
| 56 | NLK | 0.86172871 |
| 57 | IKBKB | 0.85943930 |
| 58 | CSK | 0.83268659 |
| 59 | PRPF4B | 0.82473590 |
| 60 | GSK3A | 0.81288023 |
| 61 | MAPK7 | 0.80304763 |
| 62 | MYLK | 0.80226577 |
| 63 | CDK12 | 0.70357524 |
| 64 | GRK1 | 0.67799912 |
| 65 | WNK1 | 0.66347070 |
| 66 | MAP2K3 | 0.65056980 |
| 67 | NEK6 | 0.60397704 |
| 68 | STK3 | 0.59003908 |
| 69 | TBK1 | 0.58655093 |
| 70 | STK24 | 0.58535001 |
| 71 | MAP3K11 | 0.58321118 |
| 72 | PRKG1 | 0.58284432 |
| 73 | STK39 | 0.57998380 |
| 74 | MET | 0.57645612 |
| 75 | MELK | 0.57554956 |
| 76 | MAP3K9 | 0.57307029 |
| 77 | PKN2 | 0.56575530 |
| 78 | GRK7 | 0.56342018 |
| 79 | PTK2B | 0.55883570 |
| 80 | CDC42BPA | 0.55330867 |
| 81 | ILK | 0.53784983 |
| 82 | STK38L | 0.53705662 |
| 83 | MAP2K1 | 0.52618728 |
| 84 | ADRBK2 | 0.52112423 |
| 85 | TYK2 | 0.50631160 |
| 86 | MAPKAPK3 | 0.50617187 |
| 87 | TYRO3 | 0.50162654 |
| 88 | GRK5 | 0.50038399 |
| 89 | PRKG2 | 0.49391501 |
| 90 | PDK1 | 0.48852318 |
| 91 | IGF1R | 0.48061923 |
| 92 | PAK2 | 0.47891456 |
| 93 | MAPK1 | 0.47331938 |
| 94 | MAPK3 | 0.46664325 |
| 95 | PRKACB | 0.44174958 |
| 96 | OBSCN | 0.44108582 |
| 97 | EEF2K | 0.42507477 |
| 98 | CDK4 | 0.38773685 |
| 99 | TNK2 | 0.38237201 |
| 100 | RPS6KA5 | 0.36679124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 6.02023382 |
| 2 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 5.70116923 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.89845968 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.89342338 |
| 5 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 3.30650672 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.95346413 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.57457988 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.09600445 |
| 9 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.82300758 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.75804567 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74897585 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60881588 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59598319 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.54675808 |
| 15 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.48458065 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46599133 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42834240 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41539074 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35569397 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.31505876 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26336308 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23133694 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21422866 |
| 24 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.12167098 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06358215 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05406722 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01957025 |
| 28 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99308555 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 0.97757452 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95262256 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93284735 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92751094 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90454473 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84080733 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83187130 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81868934 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79634145 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75859576 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73396926 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73010003 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73003715 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72698198 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72597402 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71737738 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69269425 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.68563658 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66568150 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66252776 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63544278 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53880371 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53111780 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.51913983 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51065860 |
| 54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50963247 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49551258 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48203152 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46524257 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44069400 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43773973 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43475308 |
| 61 | Gap junction_Homo sapiens_hsa04540 | 0.41875622 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41450183 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40650530 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39100834 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38715885 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.38452379 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.37066139 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36750838 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36542235 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35462924 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34455917 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32697360 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31733231 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29521534 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29333723 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27934176 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27648787 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26016057 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25196867 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24540637 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23582288 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.23456247 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23406143 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.22781885 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.21894858 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.21207531 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20276095 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20155087 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19369712 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.19011753 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.17379399 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.17047889 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.16773935 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15743342 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14927294 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14635287 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.14612302 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.14146356 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13971974 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13966020 |

